Edgewise Therapeutics (EWTX) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Edgewise Therapeutics (EWTX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 43M (-2.16%) | 44M (+16.30%) | 37M (+11.68%) | 34M (-8.71%) | 37M (+1.07%) | 36M (+12.88%) | 32M (+5.02%) | 31M (+10.80%) | 28M (+0.04%) | 28M (+16.35%) | 24M (+21.63%) | 20M (-1.61%) | 20M (+19.69%) | 17M (+19.58%) | 14M (+12.02%) | 12M (+11.51%) | 11M (+22.33%) | 9.09M (-8.00%) | 9.88M (+25.70%) | 7.86M (+46.64%) | 5.36M (+4.28%) | 5.14M (+58.64%) | 3.24M (-10.99%) | 3.64M (+22.56%) | 2.97M |
Selling General And Administrative | 11M (-7.51%) | 12M (+32.09%) | 9.38M (+3.65%) | 9.05M (-1.63%) | 9.20M (+0.33%) | 9.17M (+11.69%) | 8.21M (+10.50%) | 7.43M (+5.24%) | 7.06M (+14.24%) | 6.18M (+8.99%) | 5.67M (-1.90%) | 5.78M (-0.86%) | 5.83M (+6.58%) | 5.47M (+25.17%) | 4.37M (+6.85%) | 4.09M (+10.54%) | 3.70M (-0.80%) | 3.73M (+16.56%) | 3.20M (+23.08%) | 2.60M (+73.33%) | 1.50M (+23.97%) | 1.21M (+195.12%) | 410K (+28.13%) | 320K (+14.29%) | 280K |
Operating Expenses | 54M (-3.32%) | 56M (+19.46%) | 47M (+9.97%) | 43M (-7.29%) | 46M (+0.92%) | 46M (+12.64%) | 40M (+6.09%) | 38M (+9.67%) | 35M (+2.63%) | 34M (+14.97%) | 29M (+16.22%) | 25M (-1.40%) | 26M (+16.39%) | 22M (+20.92%) | 18M (+10.73%) | 16M (+11.19%) | 15M (+15.68%) | 13M (-1.99%) | 13M (+25.05%) | 10M (+52.48%) | 6.86M (+8.20%) | 6.34M (+74.18%) | 3.64M (-8.08%) | 3.96M (+21.85%) | 3.25M |
Depreciation And Amortization | 540K (-5.26%) | 570K (+14.00%) | 500K (0.00%) | 500K (-1.96%) | 510K (-15.00%) | 600K (+20.00%) | 500K (0.00%) | 500K (+6.38%) | 470K (-16.07%) | 560K (+40.00%) | 400K (0.00%) | 400K (+100.00%) | 200K (+122.22%) | 90K (-10.00%) | 100K (0.00%) | 100K (+25.00%) | 80K (+100.00%) | 40K (-60.00%) | 100K (+100.00%) | 50K (-37.50%) | 80K (+60.00%) | 50K (0.00%) | 50K (0.00%) | 50K (+25.00%) | 40K |
Operating Income | |||||||||||||||||||||||||
Operating Income | -54.11M (-3.34%) | -55.98M (+19.46%) | -46.86M (+9.97%) | -42.61M (-7.29%) | -45.96M (+0.92%) | -45.54M (+12.64%) | -40.43M (+6.09%) | -38.11M (+9.67%) | -34.75M (+2.63%) | -33.86M (+14.97%) | -29.45M (+16.22%) | -25.34M (-1.40%) | -25.70M (+16.39%) | -22.08M (+20.92%) | -18.26M (+10.73%) | -16.49M (+11.19%) | -14.83M (+15.68%) | -12.82M (-1.99%) | -13.08M (+25.05%) | -10.46M (+52.48%) | -6.86M (+8.20%) | -6.34M (+74.18%) | -3.64M (-8.08%) | -3.96M (+21.85%) | -3.25M |
Ebit | -54.11M (-3.34%) | -55.98M (+19.46%) | -46.86M (+9.97%) | -42.61M (-7.29%) | -45.96M (+0.92%) | -45.54M (+12.64%) | -40.43M (+6.09%) | -38.11M (+9.67%) | -34.75M (+2.63%) | -33.86M (+14.97%) | -29.45M (+16.22%) | -25.34M (-1.40%) | -25.70M (+16.39%) | -22.08M (+20.92%) | -18.26M (+10.73%) | -16.49M (+11.19%) | -14.83M (+15.68%) | -12.82M (-1.99%) | -13.08M (+25.05%) | -10.46M (+52.48%) | -6.86M (+8.20%) | -6.34M (+74.18%) | -3.64M (-8.08%) | -3.96M (+21.85%) | -3.25M |
EBITDA | -53.58M (-3.30%) | -55.41M (+19.52%) | -46.36M (+10.09%) | -42.11M (-7.35%) | -45.45M (+1.13%) | -44.94M (+12.55%) | -39.93M (+6.17%) | -37.61M (+9.71%) | -34.28M (+2.91%) | -33.31M (+14.66%) | -29.05M (+16.48%) | -24.94M (-2.23%) | -25.51M (+16.01%) | -21.99M (+21.09%) | -18.16M (+10.80%) | -16.39M (+11.19%) | -14.74M (+15.34%) | -12.78M (-1.54%) | -12.98M (+24.69%) | -10.41M (+53.54%) | -6.78M (+7.79%) | -6.29M (+75.21%) | -3.59M (-8.18%) | -3.91M (+21.81%) | -3.21M |
Net Income | |||||||||||||||||||||||||
Income Before Tax | - | -167.80M | - | - | - | -133.80M | - | - | - | -100.20M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -49.01M (-2.41%) | -50.22M (+23.48%) | -40.67M (+12.63%) | -36.11M (-11.50%) | -40.80M (+2.87%) | -39.66M (+16.20%) | -34.13M (+8.35%) | -31.50M (+10.45%) | -28.52M (-5.37%) | -30.14M (+17.23%) | -25.71M (+19.75%) | -21.47M (-6.00%) | -22.84M (+17.67%) | -19.41M (+10.91%) | -17.50M (+8.90%) | -16.07M (+9.62%) | -14.66M (+15.43%) | -12.70M (-1.93%) | -12.95M (+25.12%) | -10.35M (+51.98%) | -6.81M (+7.41%) | -6.34M (+74.18%) | -3.64M (-7.85%) | -3.95M (+24.21%) | -3.18M |
Net Income | -49.01M (-2.41%) | -50.22M (+23.48%) | -40.67M (+12.63%) | -36.11M (-11.50%) | -40.80M (+2.87%) | -39.66M (+16.20%) | -34.13M (+8.35%) | -31.50M (+10.45%) | -28.52M (-5.37%) | -30.14M (+17.23%) | -25.71M (+19.75%) | -21.47M (-6.00%) | -22.84M (+17.67%) | -19.41M (+10.91%) | -17.50M (+8.90%) | -16.07M (+9.62%) | -14.66M (+15.43%) | -12.70M (-1.93%) | -12.95M (+25.12%) | -10.35M (+51.98%) | -6.81M (+7.41%) | -6.34M (+74.18%) | -3.64M (-7.85%) | -3.95M (+24.21%) | -3.18M |
Comprehensive Income Net Of Tax | -49.94M (-70.19%) | -167.54M (+317.08%) | -40.17M (+10.63%) | -36.31M (-11.05%) | -40.82M (-69.42%) | -133.49M (+316.90%) | -32.02M (+1.04%) | -31.69M (+7.50%) | -29.48M (-70.13%) | -98.71M (+285.74%) | -25.59M (+17.60%) | -21.76M (+0.14%) | -21.73M (-68.27%) | -68.48M (+294.93%) | -17.34M (+5.28%) | -16.47M (+2.43%) | -16.08M (-62.89%) | -43.33M (+234.85%) | -12.94M (+25.27%) | -10.33M (+50.36%) | -6.87M (-59.87%) | -17.12M (+370.33%) | -3.64M (-7.85%) | -3.95M (+24.21%) | -3.18M |